Adam Keeney
Head of Corporate Development, Biogen.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- May 1, 2026Shares withheld for tax 455 shares at $187.06 of Biogen2
- May 1, 2026Exercised options 939 shares of Biogen2
- Feb 6, 2026Shares withheld for tax 994 shares at $201.18 of Biogen3
- Feb 6, 2026Exercised options 3,278 shares of Biogen3
- Feb 6, 2026Shares withheld for tax 589 shares at $201.18 of Biogen3
- Feb 6, 2026Exercised options 1,802 shares of Biogen3
- May 1, 2025Shares withheld for tax 454 shares at $120.93 of Biogen4
- May 1, 2025Exercised options 938 shares of Biogen4
- Feb 7, 2025Shares withheld for tax 563 shares at $141.35 of Biogen5
- Feb 7, 2025Exercised options 1,801 shares of Biogen5
- May 1, 2024Shares withheld for tax 276 shares at $216.13 of Biogen6
- May 1, 2024Exercised options 938 shares of Biogen6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 10, 2026
- 4SEC EDGARForm 4 filed May 5, 2025
- 5SEC EDGARForm 4 filed Feb 10, 2025
- 6SEC EDGARForm 4 filed May 3, 2024